Sanofi (SNYNF)

Market Cap	111.18B
Revenue (ttm)	54.85B +5.5%
Net Income	9.17B +40.5%
EPS	7.52 +44.2%
Shares Out	n/a
PE Ratio	12.12
Forward PE	9.12
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,400
Average Volume	8,241
Open	90.59
Previous Close	94.99
Day's Range	90.59 - 90.59
52-Week Range	90.05 - 122.03
Beta	0.40
RSI	38.40
Earnings Date	Jan 29, 2026

About Sanofi

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, booster, meningitis, and travel and endemic vaccines, that includes hepati...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1994
• Employees: 82,878
• Stock Exchange: OTCMKTS
• Ticker Symbol: SNYNF

Financial Performance

In 2025, Sanofi's revenue was 46.72 billion, an increase of 5.49% compared to the previous year's 44.29 billion. Earnings were 7.81 billion, an increase of 40.52%.

Financial numbers in EUR